
CPNG · NYSE
Coupang is identified in the supplied evidence as a consumer-facing company whose financial performance is reported through revenue and net income. The record does not specify its products, operating segments, customer mix, geographic footprint, or the contribution of individual businesses. At the company level, revenue increased from $30.3 billion in FY2024 to $34.5 billion in FY2025, while net income was approximately $0.2 billion in both years. Thus, the available evidence establishes a large revenue base and very thin reported profitability, but does not support a more detailed description of what Coupang sells or how segment economics differ.
Coupang rose $1.34, or 8.68%, from $15.44 to $16.78 over the supplied period. The stock initially fell to $15.16 on July 29 before reversing sharply, gaining to $16.09 on July 30, $16.35 on July 31, $16.42 on August 3, and $16.78 on August 4. The main company-specific event in the evidence was second-quarter reporting: Coupang posted a loss and narrowly missed revenue estimates, but delivered a 65.39% earnings surprise. That combination appears to have supported the rebound despite the revenue shortfall, although the supplied material does not establish the report’s publication date or identify a separate catalyst. No broader market driver or within-week reversal beyond the July 29 decline is provided.